Qingdao Vland Biotech Co (SHSE:603739) COGS-to-Revenue : 0.56 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co COGS-to-Revenue?

Qingdao Vland Biotech Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥159 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥287 Mil.

Qingdao Vland Biotech Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Qingdao Vland Biotech Co's Gross Margin % for the three months ended in Mar. 2024 was 44.46%.

Qingdao Vland Biotech Co COGS-to-Revenue Historical Data

The historical data trend for Qingdao Vland Biotech Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co COGS-to-Revenue Chart

Qingdao Vland Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.52

0.51

0.54

0.57

0.54

Qingdao Vland Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.56	0.56	0.55	0.49	0.56

Qingdao Vland Biotech Co COGS-to-Revenue Calculation

Qingdao Vland Biotech Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	644.687	/	1198.902
	=	0.54

Qingdao Vland Biotech Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	159.293	/	286.784
	=	0.56

Qingdao Vland Biotech Co (SHSE:603739) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Qingdao Vland Biotech Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	159.293 / 286.784
	=	44.46 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Qingdao Vland Biotech Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao Vland Biotech Co (SHSE:603739) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061

Website

http://www.vlandgroup.com

Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.

Executives

Chen Gang	Director
Jia De Qiang	Director
Cao Cheng	Director
Jiang Yong	senior management
Xu Yong	Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines